Tenax Therapeutics's total assets for Q2 2024 were $10.62M, a decrease of -26.58% from the previous quarter. TENX total liabilities were $1.74M for the fiscal quarter, a -14.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.